Polymorphic Salt Scavenges Toxic Aldehydes

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods lack effective solutions for treating conditions associated with aldehyde toxicity, which is implicated in various diseases and disorders, including ocular and non-ocular conditions, as there is no established treatment for scavenging toxic aldehydes such as malondialdehyde (MDA) and 4-hydroxyl-2-nonenal (HNE).

Innovation Solution

Development of specific salt forms of compounds, such as mesylate, besylate, sulfate, and phosphate salts of 6-chloro-3-amino-2-(2-hydroxypropyl)-1-azanaphthalene, which act as scavengers for toxic aldehydes, improving aqueous solubility, stability, and ease of formulation, thereby reducing the accumulation of toxic aldehydes and alleviating associated conditions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If freebase form of the compound is used, then the compound can act as an aldehyde scavenger, but the aqueous solubility is poor

Engineering Contradiction:
Improveaqueous solubilityVSAvoidformulation ease
Core Design Contradiction:
Quantity of substanceVSEase of manufacture

Solution Approach 1:

The patent applies parameter changes by converting the freebase compound into different salt forms (mesylate, besylate, sulfate, phosphate) to fundamentally alter the solubility parameter. Each salt form presents different solubility characteristics, allowing selection based on specific formulation requirements while maintaining the aldehyde scavenging activity.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates composite material systems by combining the active compound with various counterions to form distinct salt compounds. These composite salt forms integrate the pharmacophore with different anionic components, achieving both solubility improvement and maintained biological activity through the composite structure.

Inventive Principle:
Principle #40Composite materials

2Reliability

If multiple salt forms are developed, then solubility and stability are improved, but the complexity of the invention increases

Engineering Contradiction:
ImprovestabilityVSAvoidinvention complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent segments the overall solution into distinct, independently characterized salt forms. Each salt (mesylate, besylate, sulfate, phosphate) is separately prepared, characterized, and optimized for specific applications. This segmentation allows complex stability and solubility requirements to be addressed through modular selection of appropriate salt forms rather than attempting a single universal solution.

Inventive Principle:
Principle #1Segmentation

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

These salt forms effectively scavenge toxic aldehydes, reducing their levels in the body and mitigating the severity of associated diseases and disorders by forming complexes with aldehydes, thus preventing further cellular damage.

Implementation Method 1

These salt forms effectively scavenge toxic aldehydes, reducing their levels in the body and mitigating the severity of associated diseases and disorders by forming complexes with aldehydes

Methodology Applied
Scientific EffectComplex formation: Chemical Bonding

Data Source

PatentEP3596040B1Polymorphic salt of 6-chloro-3-amino-2(2-hydroxypropyl)quinoline and uses thereof
Publication Date: 2023.10.11 ALDEYRA THERAPEUTICS INC
  • EP3596040B1 patent drawingFigure 1
  • EP3596040B1 patent drawingFigure 2
  • EP3596040B1 patent drawingFigure 3

AI summary

The present invention provides freebase and salt forms, and compositions and methods thereof, useful for treating various conditions, in which aldehyde toxicity is implicated in the pathogenesis, by the administration of small molecule therapeutics acting as a scavenger for toxic aldehydes.